Among those significantly increased with BRAF+/−MEKi were 14 of 17 genes of a Th1 signature associated with immunologic rejection of cancer [25] (Figure 3B), with GNLY, IFNG, and GBP1 the only genes not represented. The gene discussed is BRAF; the disease is cancer.